Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Superior vena cava obstruction: is stenting necessary?

P Y Marcy1, N Magné, F Bentolila

  • 1Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice, France. pierre-yves.marcy@cal.nice.fnclcc.fr

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|April 18, 2001
PubMed
Summary

Superior vena cava (SVC) stenting offers a new treatment for recurrent SVC syndrome caused by tumor regrowth. This safe and effective procedure rapidly relieves symptoms and allows port catheter implantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of EGFR<sup>A289T/V</sup> mutation on relapse pattern in glioblastoma.

ESMO open·2022
Same author

Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey.

Clinical and translational radiation oncology·2022
Same author

Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma.

Revue neurologique·2022
Same author

Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFIT.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2022
Same author

[Intermediate-risk prostate cancer treated with exclusive external irradiation: Focus on anatomical sites of recurrence in two French trials].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022
Same author

Follow-up of Intracranial Aneurysms Treated by Flow Diverters: Evaluation of Parent Artery Patency Using 3D-T1 Gradient Recalled-Echo Imaging with 2-Point Dixon in Combination with 3D-TOF-MRA with Compressed Sensing.

AJNR. American journal of neuroradiology·2022

Area of Science:

  • Interventional Radiology
  • Oncology
  • Vascular Surgery

Background:

  • Recurrent superior vena cava (SVC) obstruction due to tumor regrowth after cancer therapy lacks effective treatment options.
  • Superior vena cava syndrome (SVCS) significantly impacts patient quality of life and treatment tolerance.
  • Intravascular stenting presents a novel therapeutic approach for managing vena cava syndromes.

Purpose of the Study:

  • To evaluate the safety and efficacy of intravascular stenting for treating malignant SVC syndrome.
  • To assess the patency rates and clinical outcomes of SVC stenting in cancer patients.
  • To determine the feasibility of port catheter implantation in conjunction with SVC stenting.

Main Methods:

  • A cohort of 40 cancer patients with SVC syndrome underwent computed tomography (CT) and venography.

Related Experiment Videos

  • Intravascular stenting was performed in the SVC or its tributaries for stenosis or thrombosis.
  • Clinical symptoms, stent patency, and outcomes were monitored during follow-up.

    • Main Results:

    • Stenting was technically successful in 39 out of 40 patients (97.5%).
    • Clinical symptoms of SVC syndrome resolved in 92% of treated patients.
    • Stent patency was maintained in 36 of 39 patients (92.3%) over a mean follow-up of 24 weeks.

    Conclusions:

    • SVC stenting is a safe and effective treatment for recurrent SVC syndrome, particularly in patients with malignant obstruction.
    • The procedure provides rapid symptom relief and facilitates necessary interventions like port catheter implantation.
    • Intravascular stenting demonstrates high patency rates and offers a viable therapeutic option for patients with limited treatment alternatives.